Government panel recommends emergency approval of Serum Institute’s Covovax for 7-11 year age group
"The Subject Expert Committee of Drugs Controller General Of India (DCGI) has recommended Serum Institute of India`s (SII) vaccine Covovax for children in the age group of 7-11 years," sources said.
Jun 25, 2022, 09:10 AM IST
Covid-19 fourth wave: SII slashes price of each dose of Covovax jab, check details here
SII’s Covovax was earlier included on the CoWin portal for inoculation of children aged 12-17 years at private vaccination centres.
May 03, 2022, 19:56 PM IST
NTAGI approves SII's Covid-19 vaccine Covovax for 12-17 age group, say sources
The National Technical Advisory Group on Immunization (NTAGI) on Friday approved Serum Institute of India's Covid-19 vaccine Covovax for the 12-17 age group, as per ANI.
Apr 29, 2022, 17:55 PM IST
Covovax gets recommendation from government panel, to be available for vaccination of kids in 12-17 age group
The Covid-19 Working Group has now recommended to the NTAGI`s Standing Technical Sub Committee that Covovax be included in the national vaccination programme for those aged 12 years and above, sources said.
Apr 04, 2022, 07:29 AM IST
India's drugs regulator gives nod to phase-3 clinical trial of Covovax as Covid-19 booster dose
The DCGI approved Covovax for restricted use in emergency situations in adults on December 28 last year and for inoculating the beneficiaries in the 12-17 years age group, subject to certain conditions, on March 9.
Mar 23, 2022, 18:23 PM IST
Novovax Covid-19 vaccine gets emergency use nod for those aged between 12-18 years in India
According to an official statement released by Novovax, the vaccine, also known as NVX-CoV2373, is manufactured and marketed in India by the Serum Institute of India (SII) under the brand name Covovax and is the first protein-based vaccine authorized for use in this age group in India.
Mar 23, 2022, 06:27 AM IST
SII's Covid-19 vaccine ‘Covovax’ gets emergency use nod for children aged above 12 years
"Novavax in global trials has demonstrated more than 90 per cent efficacy. Serum Institute of India`s brand Covovax has completed bridging studies in India and has been granted Emergency Use Authorisation by DCGI for adults and for children above the age of 12. Younger age groups will follow shortly," SII CEO Adar Poonawala said in a tweet.
Mar 09, 2022, 18:41 PM IST
Covid-19 vaccine for 12-17 age group - Govt panel recommends EUA for Covovax
The Drugs Controller General of India (DCGI) had approved Covovax for restricted use in emergency situation in adults on December 28. It has not yet been included in the country's vaccination drive.
Mar 04, 2022, 21:38 PM IST
Serum Institute seeks EUA for Covovax Covid-19 vaccine for 12-17 years age group
The data from two studies on about 2,707 individuals aged 12 to 17 years show Covovax is highly efficacious, immunogenic, safe and well-tolerated in this age group, said Prakash Kumar Singh, Director, Government and Regulatory Affairs at SII.
Feb 21, 2022, 18:48 PM IST
Corbevax, Covovax, Molnupiravir: All about India's 3 new COVID19 vaccines, how they will be administered
Six COVID-19 vaccines - Serum Institute's Covishield, Bharat Biotech's Covaxin, Zydus Cadila's ZyCoV-D, Russia's Sputnik V and the US-made Moderna and Johnson and Johnson - had already received EUA from the Indian drug regulator earlier.
Dec 29, 2021, 07:35 AM IST
Covovax authorisation is a vital step in India, says Novavax CEO
The Drugs Controller General of India (DCGI) has issued Emergency Use Authorization (EUA) for Covovax to prevent COVID-19 for adults 18 years old and above.
Dec 29, 2021, 07:21 AM IST
Corbevax and Covovax Vaccine Approved
2 vaccines and 1 drug related to corona have been approved. The Corbevax and Covovax vaccines have been approved.
Dec 28, 2021, 12:48 PM IST
India gets two more COVID-19 vaccines as CORBEVAX, COVOVAX approved for emergency use authorisation
Molnupiravir, an anti-viral drug, has also been approved for restricted use in an emergency situation.
Dec 28, 2021, 11:19 AM IST
CDSCO panel recommends emergency use authorisation for Covovax, Corbevax
"The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) reviewed the emergency use authorisation (EUA) application for the second time on Monday and after detailed deliberation recommended granting emergency use authorisation to Covovax and COREBEVAX," an official source said.
Dec 27, 2021, 23:47 PM IST
Covovax gets emergency use approval
In view of the increasing threat of Omicron, WHO has approved the vaccine for children, Covovax
Dec 18, 2021, 15:48 PM IST
WHO approves Serum Institute's COVID vaccine, Covovax
Covovax is a COVID-19 vaccine made by the Serum Institute of India in collaboration with the US-based Novavax.
Dec 17, 2021, 20:54 PM IST
'Covovax not approved in country of origin yet': Govt panel seeks additional data from SII
The Serum Institute of India (SII) had put in an application to the Drugs Controller General of India (DCGI) in October for grant of market authorisation of Covovax for restricted use in emergency situations.
Nov 28, 2021, 13:01 PM IST
COVID-19 vaccine: Phase 2/3 trials of Covovax in children between age 7 and 11 begins in Pune
"Pune`s Bharati Vidyapeeth Medical College Hospital began phase 2/3 trials of Covovax in children between 7 and 11 years of age on Wednesday. Nine children have been enrolled for the trial here," said Dr Sanjay Lalwani.
Oct 01, 2021, 06:21 AM IST
COVID-19: Serum Institute of India files for WHO Emergency Use Listing for its Covovax vaccine
Covovax will become SII's second coronavirus vaccine to get a WHO nod after Covishield.
Aug 21, 2021, 09:07 AM IST
Hope to launch Covovax vaccine for adults in October this year, for kids in 2022 first quarter: SII CEO Adar Poonawalla
Serum Institute of India (SII) CEO said, "The Covovax vaccine for kids will be launched in the first quarter of the next year most likely in January-February."
Aug 06, 2021, 18:52 PM IST
